Name | N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide |
Synonyms | Mepicaine Polocaine Carbocain Carbocaine DL-Mepivacaine 1-Methyl-2',6'-pipecoloxylidide 2',6'-Pipecoloxylidide, 1-methyl- (6CI, 8CI) N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl- (9CI) |
CAS | 96-88-8 |
EINECS | 202-543-0 |
Molecular Formula | C15H22N2O |
Molar Mass | 246.35 |
Density | 0.9978 (rough estimate) |
Melting Point | 150-151° |
Boling Point | 389.35°C (rough estimate) |
Water Solubility | 2.217g/L(25 ºC) |
pKa | 14.85±0.70(Predicted) |
Storage Condition | Room Temprature |
Refractive Index | 1.6280 (estimate) |
In vitro study | Mepivacaine binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization. This leads to a blockage of nerve impulse initiation and conduction and results in a reversible loss of sensation. Compared to other local anesthetics, this agent has a more rapid onset and moderate duration of action. Mepivacaine has a reasonably rapid onset (more rapid than that of procaine) and medium duration of action (shorter than that of procaine). Mepivacaine displays a preferential use-dependent block of Na(v)1.8, S(-)-bupivacaine displays a preference for TTXs Na(+) channels. |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | Mepivacaine is an amide-type agent that temporarily causes local loss of consciousness. Mepivacaine binds to specific voltage-gated sodium channels on neuronal cell membranes, inhibiting sodium influx and membrane depolarization. |